Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma

SIMPLE SUMMARY: Soft tissue sarcomas (STS) are a group of rare malignant tumors with high tissue heterogeneity and poor prognosis, and which are still without effective individualized immunotherapy approaches. In this study, four potential tumor antigens, six STS immune subtypes, and six functional...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Changwu, Duan, Yingjuan, Gong, Siming, Osterhoff, Georg, Kallendrusch, Sonja, Schopow, Nikolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774220/
https://www.ncbi.nlm.nih.gov/pubmed/35053609
http://dx.doi.org/10.3390/cancers14020448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774220/
https://www.ncbi.nlm.nih.gov/pubmed/35053609
http://dx.doi.org/10.3390/cancers14020448

Ejemplares similares